WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling
2018 ◽
Vol 233
(8)
◽
pp. 6077-6087
◽
2008 ◽
Vol 88
(2)
◽
pp. 257-262
◽
2014 ◽
Vol 6
(2)
◽
pp. 158-163
◽
2008 ◽
Vol 78
(1)
◽
pp. 27-32
◽